Publications (Google Scholar h-index 24, i-10 index 42)

 

58. Thakar S, Bhattacharya R, Katakia YT, Chakraborty S, Ramakrishnan S, Pandya Thakkar N, Dey S, Chowdhury S, Majumder S. Regulation of shelterin proteins TERF2IP and TRF2 by H3K4me3-p65 axis drives hyperglycemia dependent endothelial senescence. bioRxiv 2023.05.12.540614; doi: https://doi.org/10.1101/2023.05.12.540614. (Preprint)

 

57. Gomes GN, Thieme K, Majumder S, Morais MRPT. Editorial: Epigenetic, molecular and programming mechanisms of renal physiology and pathophysiology. Frontiers in Physiology. 2023 Feb 10;14:1158436. (Impact factor: 4.755)

 

56. Akhouri V, Majumder S, Gaikwad AB. The emerging insight into E3 ligases as the potential therapeutic target for diabetic kidney disease. Life Sciences. 2023 May 15;321:121643. (Impact factor: 6.78)

 

55. Katakia YT, Kanduri S, Bhattacharyya R, Ramanathan S, Nigam I, Kuncharam BVR, Majumder S. Angular difference in human coronary artery governs endothelial cell structure and function. Communication Biology, 2022 2022 Oct 1;5(1):1044. (Impact factor: 6.548)

 

54. Sharma S, Madhyastha H, Kirwale SS, Sakai K, Katakia YT, Majumder S, Roy A. Dual antibacterial and anti-inflammatory efficacy of a chitosan-chondroitin sulfate-based in-situ forming wound dressing. Carbohydrate Polymer, 2022 15;298:120126. (Impact factor: 10.723)

 

53. Singh H, Khadanga S, Goel SK, Majumder S, Baig MS, Bhatia V, Chaudhary N, Saluja R. Evaluation of Interleukin-33 and sST2 levels in type-2 diabetic mellitus patients with or without metabolic syndrome. 2023 Indian Journal of Medical Research 157(5):p 470-476. (Impact factor: 5.274)

 

52. Pandya-Thakkar N, Pereira BMV, Katakia YT, Ramakrishnan SK, Thakar S, Sakhuja A, Rajeev G, S Soorya, Thieme K, Majumder S. Elevated H3K4me3 through MLL2-WDR82 upon hyperglycemia causes Jagged ligand dependent Notch activation to interplay with differentiation state of endothelial cells. Frontiers in Cell and Developmental Biology, 2022 22;10:839109. (Impact factor: 6.081)

 

51. Thakar S, Katakia YT, Ramakrishnan S, Pandya-Thakkar N, Majumder S. Intermittent high glucose elevates nuclear localization of EZH2 to cause H3K27me3 dependent repression of KLF2 leading to endothelial inflammation. Cells, 2021 26;10(10):2548. (Impact factor: 7.66)

 

50. Katakia YT, Pandya-Thakkar N, Thakar S, Sakhuja A, Goyal R, Sharma H, Dave R, Mandloi A, Basu S, Nigam I, Kuncharam BVR, Chowdhury S, Majumder S. Dynamic alterations of H3K4me3 and H3K27me3 at ADAM17 and Jagged-1 gene promoters cause inflammatory switch of endothelial cells. Journal of Cellular Physiology, 2022;237(1):992-1012. (Impact factor: 6.513)

 

49. Kachwal V, Srivastava A, Thakar S, Zubiria-Ulacia M, Gautam D, Majumder S, Venkatesh KP, Casanova D, Chowdhury R, Rath N, Mukherjee S, Alemany P, Laskar IR. Engineering a light-driven cyanine based double molecular rotor to enhance the sensitivity towards the viscous medium. Material Advances, Mater. Adv., 2021,2, 4804-4813. (Impact Factor: 5.0)

 

48. Pereira BMV, Katakia YT, Majumder S, Thieme K. Unraveling the epigenetic landscape of glomerular cells in kidney disease. J Mol Med (Berl). 2021 Jun;99(6):785-803. (Impact Factor: 5.606)

 

47. Niveditha D, Jasoria M, Narayan J, Majumder S, Mukherjee S, Chowdhury R, Chowdhury S.Common and Unique microRNAs in Multiple Carcinomas Regulate Similar Network of Pathways to Mediate Cancer Progression. Sci Rep 2020, 10 (1), 2331. (Impact Factor: 4.996)

 

46. Niveditha D, Sharma H, Majumder S, Mukherjee S, Chowdhury R and Chowdhury S. Transcriptomic analysis associated with reversal of cisplatin sensitivity in drug resistant osteosarcoma cells after a drug holiday. BMC Cancer 2019 Nov 5;19(1):1045. (Impact Factor: 4.638)

 

45. Niveditha D, Sharma H, Sahu A, Majumder S, Chowdhury R and Chowdhury S. Drug Tolerant Cells: An Emerging Target With Unique Transcriptomic Features. Cancer Informatics; 2019; 18:1-5. (Impact Factor: 2.06)

 

44. Majumder S, Hadden MJ, Thieme K, Batchu SN, Niveditha D, Chowdhury S, Yerra VG, Advani SL, Bowskill BB, Liu Y, Vakili H, Alghamdi TA, White KE, Geldenhuys L, Siddiqi FS, Advani A. Dysregulated expression but redundant function of the long non-coding RNA Hotair in diabetic kidney disease. Diabetologia 2019 62(11):2129-2142. (Impact Factor: 10.46) (Cover page of Diabetologia Volume 62, Issue 11, November 2019)

 

43. Siamwala JH, Kumar P, Veeriah V, Muley A, Rajendran S, Konikkat S, Majumder S, Mani KP, Chatterjee S. Nitric Oxide Reverses the Position of the Heart during Embryonic Development. Int J Mol Sci. 2019 Mar 7;20(5). (Impact Factor: 6.208)

 

42. Niveditha D, Mukherjee S, Majumder S, Chowdhury R and Chowdhury S. A global transcriptomic pipeline decoding core network of genes involved in stages leading to acquisition of drug-resistance to cisplatin in osteosarcoma cells. Bioinformatics; 2019 May 15;35(10):1701-1711. (Impact Factor: 6.931)

 

41. Alghamdi TA, Batchu SN, Hadden M, Yerra VG, Liu Y, Bowskill B, Advani, S, Geldenhuys L, Siddiqi F, Majumder S, Advani A. Histone H3 serine 10 phosphorylation facilitates endothelial activation in diabetic kidney disease. Diabetes, 2018 Dec;67(12):2668-2681. (Impact Factor: 9.337)

 

40. Batchu SN, Thieme K, Zadeh F, Alghamdi TA, Yerra VG, Hadden M, Majumder S, Kabir MG, Bowskill BB, Ladha D, Gramolini A, Connelly KS, Advani A. The dipeptidyl peptidase-4 substrate CXCL12 has opposing cardiac effects in young mice and aged diabetic mice mediated by Ca2+ flux and phosphoinositide-3 kinase γ. Diabetes, 2018 Nov;67(11):2443-2455. (Impact Factor: 9.337)

 

39. Brijmohan AS, Batchu SN, Majumder S, Alghamdi TA, Thieme K, McGaugh S, Liu Y, Advani SL, Bowskill BB, Kabir MG, Geldenhuys L, Siddiqi F, Advani A. HDAC6 inhibition promotes transcription factor EB activation and is protective in experimental kidney disease. Front Pharmacol2018 Feb 1;9:34. (Impact Factor: 5.988)

 

38. Majumder S#, Thieme K#, Batchu SN, Alghamdi TA, Bowskill BB, Kabir MG, Liu Y, Advani SL, White KE, Geldenhuys L, Tennankore KK, Poyah P, Siddiqi FS, Advani A. Shifts in podocyte histone H3K27me3 regulate mouse and human glomerular disease. J Clin Invest. 2018 Jan 2;128(1):483-499. # contributed equally. (Impact Factor: 19.456)

Highlighted on the front cover of May 2019 Kidney News published by American Society of Nephrology.

(https://www.asn-online.org/publications/kidneynews/archives/2019/KN_2019_05_may.pdf)

Highlighted as one of the significant publication of 2018 in the “Year in Review” under diabetic kidney disease section of the Nature Reviews Nephrology (https://www.nature.com/articles/s41581-018-0092-5)

Highlighted in Nature Reviews Nephrology (https://www.nature.com/articles/nrneph.2018.1)

Highlighted in the Journal Club section of Kidney International

(https://www.kidney-international.org/article/S0085-2538(18)30137-6/fulltext)

Spotlighted by European Renal Association-European Dialysis and Transplant Association(https://enp-era-edta.org/article/276)

 

37. Rajasekeran H, Reich HN, Hladunewich MA, Cattran D, Lovshin JA, Lytvyn Y, Bjornstad P, Lai V, Tse V, Cham L, Majumder S, Bowskill BB, Kabir MG, Advani SL, Gibson IW, Sood MW, Advani A, Cherney DZI. Dapagliflozin in Focal Segmental Glomerulosclerosis: A Combined Human-Rodent Pilot Study. Am J Physiol Renal Physiol. 2018 Mar 1;314(3):F412-F422. (Impact Factor: 3.377)

 

36. Alghamdi TA, Majumder S, Thieme K, Batchu SN, White KE, Liu Y, Brijmohan AS, Bowskill BB, Advani SL, Woo M, Advani A. JAK2 regulates transcription factor EB expression and autophagy completion in glomerular podocytes. J Am Soc Nephrol. 2017 Sep;28(9):2641-2653. (Impact Factor: 14.978)

 

35. Thieme K, Majumder S, Brijmohan AS, Batchu SN, Bowskill BB, Alghamdi TA, Advani SL, Kabir MG, Liu Y, Advani A. EP4 inhibition attenuates the development of diabetic and non-diabetic experimental kidney disease. Sci Rep 2017 Jun 13;7(1):3442. (Impact Factor: 4.996)

 

34. Gajalakshmi P, Majumder S, Viebahn CS, Yeoh GC, Chatterjee S (2016) Interleukin 6 Secreted by bipotential murine oval liver stem cells induces apoptosis of activated hepatic stellate cells by activating NF-κb-inducible nitric oxide synthase signaling. Biochem. Cell Biol. 2017 Apr;95(2):263-272. (Impact Factor: 3.73)

 

33. Majumder S, Advani A. VEGF and the diabetic kidney: more than too much of a good thing. J Diabetes Complications. 2017 Jan;31(1):273-279. (Impact Factor: 3.219)

 

32. Majumder S#, Zhu G#, Xu X, Jiang D, Liu H, Xue C, Wang X, Coia H, Cui Z, Sowden M, Smolock EM, Libby RT, Berk BC, Pang J (2016) GIT1 controls stalk cell fate by inhibiting Dll4-Notch1 signaling. Cell Rep. (Cell Press)2016 Dec 6;17(10):2532-2541. # contributed equally. (Impact Factor: 9.995)

 

31. Szeto SG, Narimatsu M, Lu M, He X, Sidiqi AM, Tolosa MF, Chan L, Freitas KD, Bialik JF, Majumder S, Boo S, Hinz B, Dan Q, Advani A, John R, Wrana JL, Kapus A, Yuen DA (2016) YAP/TAZ are mechanoregulators of TGF-β-Smad signaling and renal fibrogenesis. J Am Soc Nephrol. 2016 27(10):3117-3128. (Impact Factor: 14.978)

 

30. Batchu SN, Majumder S, Bowskill BB, White KE, Advani SL, Brijmohan AS, Thai K, Azizi PM, Lee WL, Advani A (2016) Prostaglandin I2 Receptor Agonism Preserves β-Cell Function and Attenuates Albuminuria Through Nephrin-Dependent Mechanisms. Diabetes, 2016 May;65(5):1398-409. (Impact Factor: 9.337)

 

29. Siddiqi FS#, Majumder S#, Thai K, Advani SL, White KE, Bowskill BB, Hu, P, Guarna G, Abdalla M, dos Santos C, Connelly KA, Advani A (2015) The histone methyltransferase EZH2 protects against podocyte oxidative stress and renal injury in diabetes. J Am Soc Nephrol. 2016 Jul;27(7):2021-34. # contributed equally.  (Impact Factor: 14.978)

 

28. Majumder S, Advani A (2015) The epigenetic regulation of podocyte function in diabetes. J Diabetes Complications. 2015 Nov-Dec;29(8):1337-44. (Impact Factor: 3.219)

 

27. Narayanaswamy R, Majumder S, Chatterjee S, Wai LK, Arumugam G. Inhibition of Angiogenesis and Nitric Oxide Synthase (NOS), by Embelin & Vilangin Using in vitro, in vivo & in Silico Studies. Adv Pharm Bull. 2014; Suppl 2:543-548. (Impact Factor: 3.484)

 

26. Majumder S, Sinha S, Siamwala JH, Muley A, Seerapu HR, Kolluru GK, Sridhara SRC, Krishna Priya M, Kuppusamy M, Srinivasan S, Konikkat S, Soundararajan G, Nagarajan S, Venkataraman S, Saran U, Chatterjee S. A comparative study of NONOate based NO donors: Spermine NONOate is the best suited NO donor for endothelial functions. Nitric Oxide. 2014;36:76-86. (Impact Factor: 4.898)

 

25. Majumder S, Sowden MP, Gerber SA, Thomas T, Christie CK, Mohan A, Yin G, Lord EM, Berk BC, Pang J. GIT1 Is Required For Endothelial Cell Directional Migration and Tumor Angiogenesis Via Cortactin Dependent Lamellipodia Formation. Arterioscler Thromb Vasc Biol. 2014;34(2):419-26. (Impact Factor: 10.51)

 

24. Piguet AC#, Majumder S#, Saran U, Chatterjee S, Dufour JF. Everolimus is a potent inhibitor of activated hepatic stellate cell functions in vitro and in vivo, while demonstrating anti-angiogenic activities. Clin Sci (Lond)2014;126(11):775-84.  # contributed equally. (Impact Factor: 6.876)

 

23. Mukherjee AK, Chatterjee S, Majumdar S, Saikia D, Thakur R, Chatterjee A. Characterization of a pro-angiogenic, novel peptide from Russell's viper (Daboia russelii russelii) venom. Toxicon 2014;77:26- 31. (Impact Factor: 3.035)

 

22. Kolluru GK, Majumder S, Chatterjee S. Rho-kinase as a therapeutic target in vascular diseases: striking nitric oxide signaling. Nitric Oxide. 2014 Dec 1;43:45-54. (Impact Factor: 4.898)

 

21. Pang J, Xu X, Wang X, Majumder S, Wang J, Korshunov V, Berk BC. GIT 1 mediates intima formation by regulating vascular smooth muscle proliferation, apoptosis and migration. Arterioscler Thromb Vasc Biol. 2013;33(5):999-1005. (Impact Factor: 10.51)

 

20. Majumder S#, Piguet AC#, Dufour JF, Chatterjee S. Study of the Cellular Mechanism of Sunitinib Mediated Inactivation of Activated Hepatic Stellate Cells and Its Implications in Angiogenesis. Eur J Pharmacol. 2013;705(1-3):86-95. # contributed equally. (Impact Factor: 5.195)

 

19. Nagarajan S, Majumder S, Sharma U, Rajendran S, Kumar N, Chatterjee S, Singh B. Synthesis and anti-angiogenic activity of benzothiazole, benzimidazole containing phthalimide derivatives. Bioorg Med Chem Lett. 2013;23(1):287-90. (Impact Factor: 2.94)

 

18. Siamwala JH, Paul DM, Majumder S, Joshi M, Sinkar VP, Banerjee G, Chatterjee S. L-theanine promotes nitric oxide production in endothelial cells through eNOS phosphorylation. J Nutr Biochem. 2013;24(3):595-605. (Impact Factor: 6.117)

 

17. Majumder S, Sreedhara SR, Banerjee S, Chatterjee S. TNF α signaling beholds thalidomide saga: A review of mechanistic role of TNF-α signaling under thalidomide. Curr Top Med Chem, 2012;12(13):1456- 67. (Impact Factor: 3.57)

 

16. Lee J, Majumder S, Chatterjee S, Muralidhar K. Inhibitory activity of the peptides derived from buffalo prolactin on angiogenesis. J Biosci. 2011;36(2):341-354. (Impact Factor: 2.795)

 

15. Majumder S, Siamwala JH, Srinivasan S, Sinha S, Sridhara SR, Soundararajan G, Seerapu HR, Chatterjee S. Simulated microgravity promoted differentiation of bipotential murine oval liver stem cells by modulating BMP4/Notch1 signaling. J Cell Biochem. 2011;112(7):1898-1908. (Impact Factor: 4.48)

 

14. Sinha S, Sridhara SR, Srinivasan S, Muley A, Majumder S, Kuppusamy M, Gupta R, Chatterjee S. NO (nitric oxide): the ring master. Eur J Cell Biol. 2011;90(1):58-71. (Impact Factor: 6.02)

 

13. Siamwala JH#, Majumder S#, Tamilarasan KP, Muley A, Reddy SH, Kolluru GK, Sinha S, Chatterjee S. Simulated microgravity promotes nitric oxidesupported angiogenesis via the iNOS-cGMP-PKG pathway in macrovascular endothelial cells. FEBS Lett. 2010;584(15):3415-3423. # contributed equally. (Impact Factor: 3.864)

 

12. Majumder S, Ilayaraja M, Seerapu HR, Sinha S, Siamwala JH, Chatterjee S. Chick embryo partial ischemia model: A new approach to study ischemia ex vivo. PLoS one, 2010; 5:e10524. (Impact Factor: 3.752)

 

11. Seerapu HR, Subramaniam GP, Majumder S, Sinha S, Bisana S, Mahajan S, Kolluru GK, Muley A, Siamwala JH, Illavazagan G, Chatterjee S. Inhibition of dynamin-2 confers endothelial barrier dysfunctions by attenuating nitric oxide production. Cell Biol Int. 2010;34(7):755-61. (Impact Factor: 4.473)

 

10. Kolluru GK, Sinha S, Majumder S, Muley A, Siamwala JH, Gupta R, Chatterjee S. Shear stress promotes nitric oxide production in endothelial cells by sub-cellular delocalization of eNOS: A basis for shear stress mediated angiogenesis. Nitric Oxide. 2010; 15;22(4):304-315. (Cover page of Nitric oxide,Vol. 22, Issue 4) (Impact Factor: 4.898)

 

9. Siamwala JH, Reddy HS, Majumder S, Kolluru GK, Muley A, Chatterjee S. Simulated microgravity perturbs actin polymerization to promote nitric oxide associated migration of immortalized endothelial cells. Protoplasma, 2010;242(1- 4):3-12. (Impact Factor: 3.186)

 

8. Muley A, Majumder S, Kolluru GK, Parkinson S, Viola H, Hool L, Arfuso F, Ganss R, Dharmarajan A, Chatterjee S. Secreted frizzled-related protein 4: an angiogenesis inhibitor. Am J Pathol. 2010;176(3):1505- 16. (Impact Factor: 5.77)

 

7. Jetti SK, Swain SM, Majumder S, Chatterjee S, Poornima V, Bera AK. Evaluation of the role of nitric oxide in acid-sensing ion channel-mediated cell death. Nitric Oxide. 2010; 22(3):213-9. (Impact Factor: 4.898)

 

6. Majumder S, Rajaram M, Muley A, Reddy HS, Tamilarasan K, Kolluru GK, Sinha S, Siamwala JH, Gupta R, Ilavarasan R, Venkataraman S, Sivakumar K, Anishetty S, Kumar PG, Chatterjee S. Thalidomide attenuates nitric oxide-driven angiogenesis by interacting with soluble guanylyl cyclase. Br J Pharmacol. 2009 158(7); 1720-1734. (Impact Factor: 9.473)

 

5. Majumder S#, Gupta R#, Reddy HB, Sinha S, Muley A, Kolluru GK, Chatterjee S. Cadmium attenuates bradykinin driven nitric oxide production by interplaying with the localization pattern of endothelial nitric oxide synthase. Biochem. Cell Biol. 2009 87(4): 605–620. #contributed equally. (Impact Factor: 3.73)

 

4. Arora S, Tyagi YK, Kumar A, Majumder S, Saluja D, Raj HG, Chatterjee S, Saso L, Prasad AK, Parmar VS. The Role of Calreticulin Transacetylase in the Activation of Human Platelet Nitrite Reductase by Polyphenolic Acetates. Biol Pharm Bull. 2009;32(2):161-5. (Impact Factor: 1.863)

 

3. Kolluru GK, Tamilarasan KP, Rajkumar AS, Geetha Priya S, Rajaram M, Saleem NK, Majumder S, Jaffar Ali BM, Illavazagan G, Chatterjee S. Nitric oxide/cGMP protects endothelial cells from hypoxia- mediated leakiness. Eur J Cell Biol. 2008;87(3):147-61. (Impact Factor: 6.02)

 

2. Majumder S, Muley A, Kolluru GK, Saurabh S, Tamilarasan KP, Chandrasekhar S, Reddy HB, Purohit S, Chatterjee S. Cadmium reduces bioavailability of nitric oxide by impairing phosphorylation of endothelial nitric oxide synthase. Biochem Cell Biol. 2008;86(1):1-10. (Impact Factor: 3.73)

 

1. Majumder S, Tamilarasan KP, Kolluru GK, Muley A, Nair CM, Omanakuttan A, Murty KV, Chatterjee S. Activated pericyte attenuates endothelial functions: nitric oxide - cGMP rescues activated pericyte- associated endothelial dysfunctions. Biochem Cell Biol. 2007; 85(6):709-20. (Impact Factor: 3.73)